Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BioChaperone PDGF-BB in Chronic Diabetic Foot Ulcer
NCT02236793Phase 3Completed
- Sponsor
- Adocia
- Start
- Dec 2014
- Primary completion
- Aug 2016
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of becaplermin in diabetic foot ulcer (DFU), sponsored by Adocia. Started Dec 2014; status: completed.
02
Drugs
becaplermin
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT02236793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02236793.